Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemax PFS vs Eprex/Erypo for Anemia in Pre-dialysis CKD
NCT04036253Phase 3Completed
- Sponsor
- Biosidus
- Start
- Feb 2018
- Primary completion
- Jun 2021
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 2
01
Overview
A Phase 3 trial of epoetin alpha in anemia of chronic kidney disease (CKD-A), sponsored by Biosidus. Started Feb 2018; status: completed.
02
Drugs
epoetin alpha
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT04036253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04036253.